FDA inspection
Shandong Guobang Pharmaceutical Co., Ltd.: FDA inspection ending Sep 27, 2024
FDA inspection 1252414 · No Action Indicated (NAI) · Weifang
Key facts
| Inspection ID | 1252414 |
|---|---|
| Firm | Shandong Guobang Pharmaceutical Co., Ltd. |
| FEI number | 3002946929 |
| Address | Advanced Manufacturing Industrial Park, Binhai Economic Development, 02131 Xiangjiangxiyi Street |
| City | Weifang |
| Country | China |
| Fiscal year | 2024 |
| Inspection end date | Sep 27, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Pre-Approval Eval. of Animal Drugs and Food Additives |
| Product type | Veterinary |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data